What Analysts Say about the Medical Properties Trust Inc. (MPW) Stock


Medical Properties Trust Inc. (NYSE:MPW) saw an upside of 0.44% to close Monday at $13.78 after adding $0.06 on the day. The 5-day average trading volume is 10,611,920 shares of the company’s common stock. It has gained $13.90 in the past week and touched a new high 3 times within the past 5 days. An average of 12,709,100 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 12,570,074.

MPW’s 1-month performance is 26.65% or $2.63 on its low of $10.91 reached on 12/28/22. The company’s shares have touched a 52-week low of $9.90 and high of $23.18, with the stock’s rally to the 52-week high happening on 01/23/23. YTD, MPW has achieved 23.70% or $2.64 and has reached a new high 9 times. However, the current price is down -40.55% from the 52-week high price.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Insider Transactions

MPW stock investors last saw insider trading activity on Apr 07.HAMNER R STEVEN (Executive Vice President & CFO) most recently sold 285,000 shares at $21.04 per share on Apr 07. This transaction cost the insider $5,996,400. Chairman, President & CEO, Aldag Edward K JR, sold 615,000 shares at a price of $21.33 on Mar 30. Then, on Mar 10, Director Stewart Michael G sold 6,000 shares at a price of $20.26 per share. This transaction amounted to $121,560.

Valuation Metrics

MPW stock has a beta of 0.95. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 5.11 while the price-to-book (PB) in the most recent quarter is 0.93, with the price to cash flow ratio at 1.90.

As well, the company’s long term debt to equity for the quarter ending September 29 was 1.07, while the total debt to equity was 1.07. In terms of profitability, the gross margin trailing 12 months is 97.10%. The firm’s gross profit as reported stood at $671.29 million against revenue of $1.54 billion.

Earnings Surprise

For the quarterly period ending September 29 this year, Medical Properties Trust Inc.’s cash and short-term investments amounted to $305.5 million against total debt of $9.48 billion. Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 22.84% to $221.79 million, while revenue of $189.6 million was 14.51% off the previous quarter. Analysts expected MPW to announce $0.3 per share in earnings in its latest quarter, but it posted $0.37, representing a 23.30% surprise. EBITDA for the quarter stood at more than $225.35 million. Shareholders hold equity totaling $598.0 million.

Let’s look briefly at Medical Properties Trust Inc. (MPW) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 23 January was 74.55% to suggest the stock is trending Overbought, with historical volatility in this time period at 33.97%.

The stock’s 5-day moving average is $13.58, reflecting a +7.40% or $0.95 change from its current price. MPW is currently trading +28.19% above its 20-day SMA, -7.21% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +19.00% and SMA200 by-33.65%.

Stochastic %K and %D was 92.73% and 91.26% and the average true range (ATR) pointed at 0.45. The RSI (14) points at 68.98%, while the 14-day stochastic is at 95.57% with the period’s ATR at 0.47. The stock’s 9-day MACD Oscillator is pointing at 0.37 and 0.79 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for Medical Properties Trust Inc. (NYSE: MPW), BofA Securities upgraded it to a Buy rating. They previously had a Neutral rating on the stock. Analysts offering their rating for MPW stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate MPW as a “sell,”, while 6 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 7 have offered a “buy” rating.

What is MPW’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $10.00 and a high of $19.00, with their median price target at $16.00. Looking at these predictions, the average price target given by analysts is for Medical Properties Trust Inc. (MPW) stock is $15.54.


Please enter your comment!
Please enter your name here